TITLE

Defining the 'survivasome' of Mycobacterium tuberculosis

AUTHOR(S)
Lamichhane, Gyanu; Bishai, William
PUB. DATE
March 2007
SOURCE
Nature Medicine;Mar2007, Vol. 13 Issue 3, p280
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article investigates Mycobacterium tuberculosis persistence despite the availability of drugs that than can stably cure it by researchers from Baltimore, Maryland. Identification of drug targets in M. tuberculosis has been a challenge for researchers. However, high-throughput mutagenesis with transposons together with microarray-based genome and transcriptome profiling has begun to meet this challenge.
ACCESSION #
24259934

 

Related Articles

  • Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China. Shi, Dawei; Li, Liang; Zhao, Yuling; Jia, Qiong; Li, Hui; Coulter, Christopher; Jin, Qi; Zhu, Guofeng // Journal of Antimicrobial Chemotherapy (JAC);Oct2011, Vol. 66 Issue 10, p2240 

    Objectives To determine the association between embB mutations and drug resistance, and to further investigate the mechanism of embB mutations involved in the development of ethambutol and multidrug resistance in Mycobacterium tuberculosis. Methods One hundred and thirty-eight...

  • Virtually incurable TB warns of impending disaster. Mandavilli, Apoorva // Nature Medicine;Mar2007, Vol. 13 Issue 3, p271 

    The article reports on the concern of scientists regarding the emergence of extensively drug-resistant (XDR) strain of Mycobacterium tuberculosis. XDR tuberculosis (XDR-TB) is a strain that does not respond to the standard drug treatment and have appeared in virtually all countries. XDR-TB...

  • Challenges in tuberculosis drug research and development. Ginsberg, Ann M.; Spigelman, Melvin // Nature Medicine;Mar2007, Vol. 13 Issue 3, p290 

    The article discusses the challenges faced by researchers in tuberculosis (TB) drug research and development. The early part of the twenty-first century has seen a reawakening of drug research and development for TB, spurred on by an urgent need to stem the tide of the disease globally and...

  • The Evolution of Drug Resistance in Mycobacterium tuberculosis: From a Mono-Rifampin-Resistant Cluster into Increasingly Multidrug-Resistant Variants in an HIV-Seropositive Population. Bifani, Pablo; Mathema, Barun; Kurepina, Natalia; Shashkina, Elena; Bertout, Julie; Blanchis, Anne Sophie; Moghazeh, Soraya; Driscoll, Jeffrey; Gicquel, Brigitte; Frothingham, Richard; Kreiswirth, Barry N. // Journal of Infectious Diseases;7/1/2008, Vol. 198 Issue 1, p90 

    We describe the genotypic and phenotypic characteristics of a mono-rifampin-resistant (RIFR) Mycobacterium tuberculosis strain cluster (designated AU-RIFR) and the acquisition of additional drug resistance. Drug susceptibility, sequences of regions that determine drug resistance, and basic...

  • Bringing Down the Wall of the Mycobacterium tuberculosis Fortress: Old and New Inhibitors of Mycolic Acid Biosynthesis. Morbidoni, Héctor R. // Current Respiratory Medicine Reviews;2009, Vol. 5 Issue 3, p190 

    Mycobacterium tuberculosis (the causative agent of tuberculosis), is a stealthy pathogen with a great ability to successfully infect humans and a strong will to stay in the host as long as possible. As much as one admires it as a microbiological entity, M. tuberculosis is also a killer at...

  • Vigilancia de la resistencia a los fármacos antituberculosos en Cuba, 2000-2009. Montoro, Ernesto; Lemus, Dihadenys; Echemendia, Miguel; Diaz, Raúl; Mederos, Lilian; Martinez, Maria Rosarys; Llop, Alina; Llanes, Maria Josefa // Pan American Journal of Public Health;Dec2011, Vol. 30 Issue 6, p615 

    Objective. Determine the prevalence of resistance to antitubercular drugs in Cuba in the 2000-2009 decade. Methods. A prospective longitudinal study was conducted. The sample group consisted of 2 285 Mycobacterium tuberculosis isolates obtained from throughout the country in the period from 1...

  • Fluoroquinolone-resistant tuberculosis at a medical centre in Taiwan, 2005–10. Lai, Chih-Cheng; Tan, Che-Kim; Huang, Yu-Tsung; Liao, Chun-Hsing; Hsueh, Po-Ren // Journal of Antimicrobial Chemotherapy (JAC);Oct2011, Vol. 66 Issue 10, p2437 

    The article discusses a study which assessed the characteristics of patients with ofloxacin-resistant Mycobacterium tuberculosis in Taiwan. A low rate of fluoroquinolone-resistant M. tuberculosis in Northern Taiwan was reported. The rate of fluoroquinalone resistance was found to be highest...

  • Mycobacterial Interspersed Repetitive Unit typing in Mycobacterium tuberculosis isolates from Sichuan Province in China. Jian-hua Guo; Wen-liang Xiang; Geng Zhang; Tao Luo; Ning Xie; Zhi-rong Yang; Qun Sun // Indian Journal of Medical Research;Sep2011, Vol. 134 Issue 3, p362 

    Background & objectives: Emergence and spread of d rug resistant Mycobacterium tuberculosis is a serious threat to tuberculosis (TB) control programme. Therefore, the objective of this study was to genotype drug-resistant M. tuberculosis strains isolated from patients in Sichuan, China, using...

  • Increasing Drug Resistance in Extensively Drug-Resistant Tuberculosis, South Africa. Shah, N. Sarita; Richardson, Jessica; Moodley, Prashini; Moodley, Salona; Babaria, Palav; Ramtahal, Melissa; Heysell, Scott K.; Xuan Li; Moll, Anthony P.; Friedland, Gerald; Sturm, A. Willem; Gandhi, Neel R. // Emerging Infectious Diseases;Mar2011, Vol. 17 Issue 3, p510 

    We expanded second-line tuberculosis (TB) drug susceptibility testing for extensively drug-resistant Mycobacterium tuberculosis isolates from South Africa. Of 19 patients with extensively drug-resistant TB identified during February 2008-April 2009, 13 (68%) had isolates resistant to all 8 drugs...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics